JPMorgan Conducts On-Site Research on Tesla: Two Core Narratives—Robotaxi and Optimus—Their Commercialization Path Is Gradually Becoming Clear.

The expansion of Tesla’s Robotaxi fleet will see a clear acceleration from late 2026 to early 2027, with the key trigger already identified: the in-year release of FSD v15. For Optimus, the Gen 3 design has been finalized, the supply chain is largely locked in, and after the start of mass production (SoP), the initial deployment target is to enter the “Optimus Academy” training phase in the second half of 2026, with external commercial sales achieved as early as the second half of 2027.

Tesla’s two core narratives—scaling up Robotaxi deployments and commercializing Optimus humanoid robots—are moving from concept to an execution path that can be quantified. JPMorgan recently carried out an on-site research visit at Tesla’s Fremont factory and held meetings with the company’s investor relations team. Overall, the analysts gave positive assessments of the advancement pace for the two business lines, believing that both are broadly aligned with the timeline previously disclosed by management.

According to a JPMorgan report, the key trigger for expanding the Robotaxi fleet has been clearly pinned to the in-year launch of FSD v15. Management said that technical validation work for a small-scale Cybercab test fleet is continuing, and about 40% of the core v15 technical modules have already been tested in the Robotaxi fleet, with initial feedback described as positive;

At the same time, the company intends to control the number of Model Y units converted to the Robotaxi fleet, indicating confidence in the near-term ability to deliver Cybercab at scale.

For Optimus, the Gen 3 design has been finalized, the supply chain is largely locked in, and production lines are being installed at the Fremont factory. After mass production starts (SoP), the initial deployment target is to enter the “Optimus Academy” training phase in the second half of 2026, with external commercial sales as early as the second half of 2027.

JPMorgan maintains a Neutral rating on Tesla with a target price of $445. At the time the report was published, the stock price was $339.30. The analysts’ view is that the expansion of the Robotaxi fleet will accelerate noticeably from late 2026 to early 2027; the Optimus commercialization path is clear, and an improving FSD penetration rate, together with a lineup of new vehicle models, will support a near-term rebound in demand.

Robotaxi scaling up: FSD v15 is the key switch

Optimus: Production line installation underway; commercialization path in three stages

FSD: From configuration options to the core driver of purchasing

Demand recovery coexists with pressure on gross margins